Selected article for: "co evolution and viral evolution"

Author: Shen, Zu T.; Sigalov, Alexander B.
Title: SARS Coronavirus Fusion Peptide-Derived Sequence Suppresses Collagen-Induced Arthritis in DBA/1J Mice
  • Document date: 2016_6_28
  • ID: 10wcqgaq_3
    Snippet: In this study, we demonstrate that a synthetic 11 amino acid-long peptide (MG11) derived from SARS CoV FP reduces inflammation in DBA/1J mice with collagen-induced arthritis (CIA) and protects mice against bone and cartilage damage. The effect is specific as administration of the control peptide has no effect. Incorporation of MG11 into synthetic nanoparticles that mimic human high density lipoproteins (HDL) substantially reduces the effective pe.....
    Document: In this study, we demonstrate that a synthetic 11 amino acid-long peptide (MG11) derived from SARS CoV FP reduces inflammation in DBA/1J mice with collagen-induced arthritis (CIA) and protects mice against bone and cartilage damage. The effect is specific as administration of the control peptide has no effect. Incorporation of MG11 into synthetic nanoparticles that mimic human high density lipoproteins (HDL) substantially reduces the effective peptide dosage. In summary, our data demonstrate for the first time that SARS-CoV FP does not only have fusogenic, but also immunomodulatory activity. This study provides compelling experimental in vivo evidence in support of our hypothesis 29 and further confirms that viral immune evasion strategies evolved during host-virus co-evolution can be transferred to therapeutic strategies that require similar functionalities (e.g., in the treatment of autoimmune diseases).

    Search related documents:
    Co phrase search for related documents
    • acid long peptide and immune evasion: 1
    • acid long peptide and immunomodulatory activity: 1
    • acid long peptide and therapeutic strategy: 1
    • autoimmune disease and cartilage damage: 1
    • autoimmune disease and HDL high density lipoprotein: 1
    • autoimmune disease and high density: 1, 2
    • autoimmune disease and high density lipoprotein: 1
    • autoimmune disease and host virus: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • autoimmune disease and immune evasion: 1
    • autoimmune disease and immunomodulatory activity: 1
    • autoimmune disease and inflammation reduce: 1, 2
    • autoimmune disease and therapeutic strategy: 1, 2, 3, 4, 5, 6
    • autoimmune disease treatment and inflammation reduce: 1
    • autoimmune disease treatment and therapeutic strategy: 1
    • cartilage damage and co evolution: 1
    • cartilage damage and control peptide: 1, 2
    • cartilage damage and effective peptide dosage: 1
    • cartilage damage and high density: 1
    • cartilage damage and immune evasion: 1